Business Context and Reporting Period
This Form 8-K is a current report filed by Global Medical REIT Inc. (not Chiron Real Estate Inc.) on March 7, 2018, covering events occurring on March 5 and March 6, 2018. The Company is a Maryland corporation focused on acquiring and managing medical office buildings.
Key Financial Metrics and Transactions
- Acquisition: Entered into an agreement to acquire the Belpre Portfolio (four medical office buildings, 155,600 sq. ft.) for $64,200,000.
- Payment Structure: Up to $5,500,000 of the purchase price may be paid in Operating Partnership (OP) Units at a price of no lower than $9.00 per unit.
- Lease Metrics: The portfolio is leased to Memorial Health System with a weighted average remaining lease term of 13.3 years and aggregate initial annual rent of approximately $5.1 million.
- Debt Facility: Amended its senior revolving credit facility to increase the commitment amount to $340 million.
- Dividends: Declared a common stock dividend of $0.20 per share (Q1 2018) and a Series A Preferred Stock dividend of $0.46875 per share.
Material Changes and Agreements
The primary material change is the entry into the Belpre Purchase Agreement. The Company has deposited $1,000,000 in earnest money, with an additional $1,000,000 required if the agreement is not terminated by April 5, 2018. The Company retains the right to terminate the agreement without penalty prior to April 5, 2018, based on due diligence results. Additionally, the Company amended its credit facility to increase borrowing capacity, though the specific borrowing base valuation limits remain in effect.
Guidance, Outlook, and Management Commentary
The filing does not provide updated financial guidance or forward-looking revenue projections. Management commentary is limited to the announcement of the Belpre acquisition and the credit facility amendment. The Company believes the acquisition is probable but notes there is no assurance of closing. The filing also details the approval of 2018 Long-Term Incentive Plan (LTIP) awards for executive officers and directors, tied to Total Shareholder Return (TSR) performance metrics.
Investor Verification Checklist
- Verify the closing status of the Belpre Portfolio acquisition and whether the $2,000,000 total earnest money deposit was retained or refunded.
- Confirm the actual amount of the purchase price paid in OP Units versus cash, if the transaction closes.
- Review the specific borrowing base valuation limits under the amended $340 million credit facility to assess immediate liquidity availability.
- Monitor the vesting conditions for the 2018 LTIP awards, specifically the TSR thresholds (21% absolute and 35th percentile relative) required to earn performance units.
- Check subsequent filings for the final terms of the credit facility amendment, as the full text was scheduled for filing in the Q1 2018 Form 10-Q.